Abstract
Transurethral resection of the prostate (TURP) is the most common surgical procedure for relieving symptoms of benign prostatic hyperplasia. Here, we report our experience of current indications for TURP and their associated outcomes at Kaohsiung Medical University Hospital (KMUH). A total of 111 patients who underwent TURP at KMUH between May 2000 and December 2001 were included in this retrospective review. For each patient, the surgical indication was categorized into acute urinary retention, chronic complications (including renal impairment, recurrent urinary infection, bladder stone/diverticulum, post‐void residue, and recurrent hematuria), and symptomatic prostatism. Thirty‐five patients (31%) had acute urinary retention, 28 (27%) had chronic complications, and 48 (42%) had symptomatic prostatism. Most patients chose TURP only when medical treatment had failed to relieve symptoms, no matter what category they belonged to. Patients with acute urinary retention and chronic complications had larger prostates (p = 0.002) and more tissue resected (p = 0.05) than those with symptomatic prostatism. Patients with acute urinary retention seemed to be at greater risk of postoperative complications such as recurrent urinary retention and urinary tract infection. We suggest that urodynamic study may be necessary to rule out concomitant bladder dysfunction before surgery and that adequate prophylactic antibiotic treatment be used to decrease the risk of urinary tract infection during or after TURP, especially when pyuria is noted preoperatively in patients with acute urinary retention.
Keywords: transurethral resection, prostate, benign prostatic hyperplasia
Full Text
The Full Text of this article is available as a PDF (109.6 KB).
References
- 1. Chute CG, Panser LA, Girman CJ, et al. The prevalence of prostatism: a population‐based survey of urinary symptoms. J Urol. 1993; 150: 85–89. [DOI] [PubMed] [Google Scholar]
- 2. Borth CS, Beiko DT, Nickel JC. Impact of medical therapy on transurethral resection of the prostate: a decade of change. Urology. 2001; 57: 1082–1086. [DOI] [PubMed] [Google Scholar]
- 3. Nickel JC. Long‐term implications of medical therapy on benign prostatic hyperplasia end points. Urology. 1998; 51 (Suppl 4A): 50–57. [DOI] [PubMed] [Google Scholar]
- 4. Wasson JH, Bubolz TA, Lu‐Yao GL, et al. Transurethral resection of the prostate among Medicare beneficiaries: 1984 to 1997. J Urol. 2000; 164: 1212–1215. [PubMed] [Google Scholar]
- 5. Flanigan RC, Reda DJ, Wasson JH, et al. 5‐year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol. 1998; 160: 12–17. [PubMed] [Google Scholar]
- 6. Hartung H. Do alpha‐blockers prevent the occurrence of acute urinary retention?. Eur Urol. 2001; 39: 13–18. [DOI] [PubMed] [Google Scholar]
- 7. Roberts RO, Jacobsen SJ, Rhodes T, et al. Natural history of prostatism: impaired health states in men with lower urinary tract symptoms. J Urol. 1997; 157: 1711–1717. [DOI] [PubMed] [Google Scholar]
- 8. Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how?. Eur Urol. 1999; 36: 7–13. [DOI] [PubMed] [Google Scholar]
- 9. Speakman MJ. Who should be treated and how? Evidence‐based medicine in symptomatic BPH. Eur Urol. 1999; 36: 40–51. [DOI] [PubMed] [Google Scholar]
- 10. Gordon NS, Hadlow G, Knight E, Mohan P. Transurethral resection of the prostate: still the gold standard. Aust NZ J Surg. 1997; 67: 354–357. [DOI] [PubMed] [Google Scholar]
- 11. Donovan JL, Peters TJ, Neal DE, et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostate enlargement: the CLasP study. J Urol. 2000; 164: 65–70. [PubMed] [Google Scholar]
- 12. Anson K, Nawrocki J, Buckley J, et al. A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology. 1995; 46: 305–310. [DOI] [PubMed] [Google Scholar]
- 13. Cowles RS 3rd, Kabalin JN, Childs S, et al. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology. 1995; 46: 155–160. [DOI] [PubMed] [Google Scholar]
- 14. Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. New Engl J Med. 1995; 322: 75–79. [DOI] [PubMed] [Google Scholar]
- 15. Gerber GS. Benign prostatic hyperplasia in older men. Clin Geriatr Med. 1998; 24: 317–331. [PubMed] [Google Scholar]
- 16. Hakenberg OW, Helke C, Manseck A, Wirth MP. Is there a relationship between the amount of tissue removed at transurethral resection of the prostate and clinical improvement in benign prostatic hyperplasia. Eur Urol. 2001; 39: 412–417. [DOI] [PubMed] [Google Scholar]
- 17. Chen SS, Hong JG, Hsiao YJ, Chang LS. The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia. BJU Int. 2000; 85: 79–82. [DOI] [PubMed] [Google Scholar]
- 18. Aagaard J, Jonler M, Fuglsig S, et al. Total transurethral resection versus minimal transurethral resection of prostate — a 10 year follow‐up study of urinary symptoms, uroflowmetry and residual volume. Br J Urol. 1994; 74: 333–336. [DOI] [PubMed] [Google Scholar]